.svg){kind=small}
Sep-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Pot & Head is stocked at 136 licensed dispensaries across New York, with the deepest coverage in New York, Brooklyn, Staten Island, Rochester, and Buffalo. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In September 2026, Pot & Head’s mix tilted toward Flower at 38.05% share (ranked first within its own portfolio by share) despite a 63.73% year-over-year decline and a 6.72% month-over-month drop, while Concentrates rose to 27.72% share with a 23.98% month-over-month gain against a 27.66% year-over-year decline. Pre-Roll held 22.12% share with a 59.90% year-over-year contraction and a 5.24% month-over-month dip, as Vapor Pens reached 12.11% share with a 13.46% month-over-month increase and no year-over-year baseline. With total brand sales down 49.59% year over year and average price up 5.60%, the mix shift toward faster month-over-month movers (Concentrates and Vapor Pens) implies the brand is reallocating momentum away from steeply declining year-over-year segments toward categories that can stabilize share near term.
The juxtaposition of a 23.98% month-over-month rise in Concentrates and a 13.46% month-over-month increase in Vapor Pens, alongside Flower’s 6.72% month-over-month decline and Pre-Roll’s 5.24% month-over-month decline, indicates a pivot toward higher-velocity inhalables where short-cycle demand is firmer, even as year-over-year comps remain negative in larger segments. Given New York-facing placement in Concentrates at rank 21 and a brandwide 49.59% year-over-year sales contraction, the pattern suggests near-term execution is tilting toward regaining visibility in formats with quicker repeat rates while ceding volume in Flower and Pre-Roll until pricing and velocity recover.
Competitive Landscape
Pot & Head sits at rank 21 in New York Concentrates in September 2026, sliding 3 positions from rank 18 year over year, yet improving 5 ranks versus June 2026 when it was 26; this contrasts with RYTHM improving from rank 4 to rank 2 and Jetpacks declining from rank 2 to rank 3 alongside a -7.97% sales change. The brand remains 11 spots below its peak at rank 10 from November 2025 while Mfny (Marijuana Farms New York) held rank 1 year over year with a 43.71% sales gain, and UMAMII surged from rank 21 to rank 4 with 680.13% sales growth; the pattern implies Pot & Head’s mid-pack stabilization is being outpaced by top-tier acceleration, requiring either mix shifts or promotional repositioning to reclaim double-digit ranks.
Notable Products
Blue Dream Pre-Roll (1g) posted the steepest decline at -45.4% MoM while sinking to rank 9, signaling a sharp retreat in a segment where Tahoe OG Pre-Roll (1g) rose 32.9% MoM to rank 2. Pre-Rolls accounted for six of the top ten slots, and within that cluster ADK Kush Hash Infused Pre-Roll (1g) fell -32.3% MoM to rank 5 as Meat Breath Pre-Roll (1g) climbed 27.4% MoM to hold rank 1. The concentration of six Pre-Roll SKUs in the top ten alongside two Concentrates implies Pot & Head is skewing toward quick-turn inhalables while pruning underperforming infused formats.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
